- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Patent holdings for IPC class C07K 16/28
Total number of patents in this class: 51103
10-year publication summary
|
2480
|
2884
|
3456
|
3730
|
4051
|
4197
|
4143
|
4642
|
4372
|
800
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4563 |
1075 |
| Genentech, Inc. | 4058 |
804 |
| Hoffmann-La Roche Inc. | 3640 |
621 |
| F. Hoffmann-La Roche AG | 7882 |
598 |
| The Regents of the University of California | 20447 |
587 |
| Amgen Inc. | 4318 |
580 |
| Immatics Biotechnologies GmbH | 1133 |
566 |
| Novartis AG | 10463 |
563 |
| Bristol-myers Squibb Company | 4793 |
559 |
| Janssen Biotech, Inc. | 1652 |
491 |
| Memorial Sloan-Kettering Cancer Center | 2006 |
441 |
| Chugai Seiyaku Kabushiki Kaisha | 1395 |
407 |
| The Trustees of the University of Pennsylvania | 4396 |
356 |
| The Board of Trustees of the Leland Stanford Junior University | 6597 |
331 |
| Board of Regents, The University of Texas System | 6028 |
315 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
312 |
| Genmab A/S | 459 |
303 |
| Xencor, Inc. | 403 |
292 |
| Dana-Farber Cancer Institute, Inc. | 2641 |
273 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2958 |
268 |
| Other owners | 41361 |